Sign in
4

Changes in Ownership

ATOSSA THERAPEUTICS, INC. Filed Acc 0001144204-16-103735

Options or other derivatives

  • CFO, Gen Counsel and Secretary acquired 1,090,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Guse Kyle CFO, Gen Counsel and Secretary 2016-05-18 Grant or award · Stock Option (right to buy) +1,090,000 1,090,000 D
Loading xslF345X03/v440540_4.xml…